Related Experiment Videos

Experimental induction of hepatocellular hyalin (Mallory bodies) in mice by griseofulvin treatment. 1. Light

Insights

Griseofulvin (GF) causes liver damage and hepatoma in mice, forming Mallory bodies (MB) in liver cells. MB formation is reversible upon drug withdrawal, indicating a direct link to GF-induced metabolic changes.

Area of Science:

  • Hepatology
  • Toxicology
  • Experimental Pathology

Background:

  • Griseofulvin (GF) is an antifungal medication.
  • Hepatocellular hyalin, resembling Mallory bodies (MB), is observed in various human liver diseases.

Purpose of the Study:

  • To investigate the effects of Griseofulvin (GF) on liver pathology in mice.
  • To characterize the formation and resolution of hepatocellular hyalin (Mallory bodies) induced by GF.

Main Methods:

  • Mice were fed Griseofulvin (GF) to induce liver damage and hepatoma.
  • Histopathological examination of liver tissues was performed.
  • Morphological and tinctorial properties of Mallory bodies (MB) were analyzed.

Main Results:

  • GF feeding led to protoporphyria, liver cell damage, bile duct alterations, and hepatoma formation.
  • Hepatocellular hyalin, morphologically similar to Mallory bodies (MB), developed in hepatocytes.
  • MB formation was reversible upon GF discontinuation and reappeared upon resumption, suggesting a direct drug-induced metabolic link.

Conclusions:

  • Griseofulvin (GF) induces liver injury and hepatoma formation in mice.
  • The formation of hepatocellular hyalin (Mallory bodies) is a reversible consequence of GF-induced metabolic alterations.
  • GF-treated livers are primed for rapid MB formation upon re-exposure to the drug.

Related Concept Videos